Tissue Regenix Group PLC (LON:TRX)

Tissue Regenix Group PLC (LON:TRX)

Share Price
3.96 p
-0.44 (-10.00 %)
Market Cap
£46.41 m
Proactive Investors - Run By Investors For Investors

Tissue Regenix Group PLC

TISSUE REGENIX GROUP is a pioneering, international medical technology company, focusing on the development of regenerative products utilising our two platform technologies, dCELL®, addressing soft tissue needs, and BioRinseTM, providing inductive bone allografts.

We are helping to transform the treatment of patients in three key areas: BioSurgery, Orthopaedics & Dental and Cardiac.

Market: AIM:TRX
52-week High/Low: 10.70p / 3.10p
Sector: Pharma & Biotech
Market Cap: £46.41 m
Website: www.tissueregenix.com
col 3
col 4
col 5
col 6

Big Picture – A Deep Dive Examination of Tissue Regenix Group PLC

Tissue Regenix Group PLC Timeline

Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use